472 related articles for article (PubMed ID: 29980189)
1. Clinical course and significance of nontuberculous mycobacteria and its subtypes in cystic fibrosis.
Eikani MS; Nugent M; Poursina A; Simpson P; Levy H
BMC Infect Dis; 2018 Jul; 18(1):311. PubMed ID: 29980189
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of nontuberculous mycobacterial infections and associated chronic macrolide use among persons with cystic fibrosis.
Binder AM; Adjemian J; Olivier KN; Prevots DR
Am J Respir Crit Care Med; 2013 Oct; 188(7):807-12. PubMed ID: 23927602
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of Pulmonary Nontuberculous Mycobacterial Sputum Positivity in Patients with Cystic Fibrosis in the United States, 2010-2014.
Adjemian J; Olivier KN; Prevots DR
Ann Am Thorac Soc; 2018 Jul; 15(7):817-826. PubMed ID: 29897781
[TBL] [Abstract][Full Text] [Related]
4. Increasing nontuberculous mycobacteria infection in cystic fibrosis.
Bar-On O; Mussaffi H; Mei-Zahav M; Prais D; Steuer G; Stafler P; Hananya S; Blau H
J Cyst Fibros; 2015 Jan; 14(1):53-62. PubMed ID: 24917112
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of a first positive nontuberculous mycobacteria culture in cystic fibrosis.
Martiniano SL; Sontag MK; Daley CL; Nick JA; Sagel SD
Ann Am Thorac Soc; 2014 Jan; 11(1):36-44. PubMed ID: 24251858
[TBL] [Abstract][Full Text] [Related]
6. Nontuberculous mycobacteria: the changing epidemiology and treatment challenges in cystic fibrosis.
Leung JM; Olivier KN
Curr Opin Pulm Med; 2013 Nov; 19(6):662-9. PubMed ID: 24048085
[TBL] [Abstract][Full Text] [Related]
7. Nontuberculous mycobacteria in patients with cystic fibrosis.
Leung JM; Olivier KN
Semin Respir Crit Care Med; 2013 Feb; 34(1):124-34. PubMed ID: 23460012
[TBL] [Abstract][Full Text] [Related]
8. Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis.
Olivier KN; Weber DJ; Wallace RJ; Faiz AR; Lee JH; Zhang Y; Brown-Elliot BA; Handler A; Wilson RW; Schechter MS; Edwards LJ; Chakraborti S; Knowles MR;
Am J Respir Crit Care Med; 2003 Mar; 167(6):828-34. PubMed ID: 12433668
[TBL] [Abstract][Full Text] [Related]
9. Nontuberculous mycobacteria in cystic fibrosis patients on the Island of Gran Canaria. A population study.
Campos-Herrero MI; Chamizo FJ; Caminero JA; Gilarranz R; Cabrera G; Cuyás J
J Infect Chemother; 2016 Aug; 22(8):526-31. PubMed ID: 27262751
[TBL] [Abstract][Full Text] [Related]
10. Reduced risk of nontuberculous mycobacteria in cystic fibrosis adults receiving long-term azithromycin.
Coolen N; Morand P; Martin C; Hubert D; Kanaan R; Chapron J; Honoré I; Dusser D; Audureau E; Veziris N; Burgel PR
J Cyst Fibros; 2015 Sep; 14(5):594-9. PubMed ID: 25735458
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of Nontuberculous Mycobacteria Infection in Children and Young People With Cystic Fibrosis: Analysis of UK Cystic Fibrosis Registry.
Gardner AI; McClenaghan E; Saint G; McNamara PS; Brodlie M; Thomas MF
Clin Infect Dis; 2019 Feb; 68(5):731-737. PubMed ID: 29982302
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of nontuberculous mycobacteria (NTM) amongst individuals with cystic fibrosis (CF).
Viviani L; Harrison MJ; Zolin A; Haworth CS; Floto RA
J Cyst Fibros; 2016 Sep; 15(5):619-23. PubMed ID: 27050794
[TBL] [Abstract][Full Text] [Related]
13. High incidence of non-tuberculous mycobacteria-positive cultures among adolescent with cystic fibrosis.
Cavalli Z; Reynaud Q; Bricca R; Nove-Josserand R; Durupt S; Reix P; Perceval M; de Montclos MP; Lina G; Durieu I
J Cyst Fibros; 2017 Sep; 16(5):579-584. PubMed ID: 28202251
[TBL] [Abstract][Full Text] [Related]
14. Screening practices for nontuberculous mycobacteria at US cystic fibrosis centers.
Low D; Wilson DA; Flume PA
J Cyst Fibros; 2020 Jul; 19(4):569-574. PubMed ID: 32178969
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology of nontuberculous mycobacteria among patients with cystic fibrosis in Scandinavia.
Qvist T; Gilljam M; Jönsson B; Taylor-Robinson D; Jensen-Fangel S; Wang M; Svahn A; Kötz K; Hansson L; Hollsing A; Hansen CR; Finstad PL; Pressler T; Høiby N; Katzenstein TL;
J Cyst Fibros; 2015 Jan; 14(1):46-52. PubMed ID: 25178871
[TBL] [Abstract][Full Text] [Related]
16. Nontuberculous mycobacteria in cystic fibrosis associated with allergic bronchopulmonary aspergillosis and steroid therapy.
Mussaffi H; Rivlin J; Shalit I; Ephros M; Blau H
Eur Respir J; 2005 Feb; 25(2):324-8. PubMed ID: 15684298
[TBL] [Abstract][Full Text] [Related]
17. Household proximity to water and nontuberculous mycobacteria in children with cystic fibrosis.
Bouso JM; Burns JJ; Amin R; Livingston FR; Elidemir O
Pediatr Pulmonol; 2017 Mar; 52(3):324-330. PubMed ID: 28135043
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and clinical outcomes of nontuberculous mycobacteria in a Brazilian cystic fibrosis reference center.
Aiello TB; Levy CE; Zaccariotto TR; Paschoal IA; Pereira MC; Nolasco da Silva MT; Ribeiro JD; Ribeiro AF; Toro AADC; Mauch RM
Pathog Dis; 2018 Jul; 76(5):. PubMed ID: 29846573
[TBL] [Abstract][Full Text] [Related]
19. An evaluation of methods for the isolation of nontuberculous mycobacteria from patients with cystic fibrosis, bronchiectasis and patients assessed for lung transplantation.
Stephenson D; Perry A; Appleby MR; Lee D; Davison J; Johnston A; Jones AL; Nelson A; Bourke SJ; Thomas MF; De Soyza A; Lordan JL; Lumb J; Robb AE; Samuel JR; Walton KE; Perry JD
BMC Pulm Med; 2019 Jan; 19(1):19. PubMed ID: 30665395
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Various Culture Media for Detection of Rapidly Growing Mycobacteria from Patients with Cystic Fibrosis.
Preece CL; Wichelhaus TA; Perry A; Jones AL; Cummings SP; Perry JD; Hogardt M
J Clin Microbiol; 2016 Jul; 54(7):1797-1803. PubMed ID: 27098962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
